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Mechanisms of gene regulation are poorly understood in Apicomplexa, a phylum that encompasses deadly human
pathogens like Plasmodium and Toxoplasma. Initial studies suggest that epigenetic phenomena, including histone
modifications and chromatin remodeling, have a profound effect upon gene expression and expression of virulence
traits. Using the model organism Toxoplasma gondii, we characterized the epigenetic organization and transcription
patterns of a contiguous 1% of the T. gondii genome using custom oligonucleotide microarrays. We show that
methylation and acetylation of histones H3 and H4 are landmarks of active promoters in T. gondii that allow us to
deduce the position and directionality of gene promoters with .95% accuracy. These histone methylation and
acetylation ‘‘activation’’ marks are strongly associated with gene expression. We also demonstrate that the pattern of
histone H3 arginine methylation distinguishes certain promoters, illustrating the complexity of the histone
modification machinery in Toxoplasma. By integrating epigenetic data, gene prediction analysis, and gene expression
data from the tachyzoite stage, we illustrate feasibility of creating an epigenomic map of T. gondii tachyzoite gene
expression. Further, we illustrate the utility of the epigenomic map to empirically and biologically annotate the
genome and show that this approach enables identification of previously unknown genes. Thus, our epigenomics
approach provides novel insights into regulation of gene expression in the Apicomplexa. In addition, with its compact
genome, genetic tractability, and discrete life cycle stages, T. gondii provides an important new model to study the
evolutionarily conserved components of the histone code.
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Introduction
Toxoplasma gondii is an obligate intracellular apicomplexan
parasite responsible for encephalitis in immunocompromised
individuals and birth defects when a fetus is exposed in utero
[1,2]. The life cycle of T. gondii is complex, with multiple
differentiation steps that are critical to survival of the
parasite in its human and feline hosts [3]. The genetic
tractability of T. gondii has caused it to emerge as a model for
the study of apicomplexan parasites [3], and the recent
sequencing of the T. gondii genome (http://www.toxodb.org) is
adding to our appreciation of the unusual nature of
apicomplexan genomes [4,5].
A remarkable ﬁnding is the relative paucity of genes
encoding proteins with motifs that indicate transcription
factor function in apicomplexan genomes [6,7]. This has led
to the proposal that gene regulation in apicomplexan
parasites is controlled mainly via RNA stability [6], despite
the tightly regulated patterns of gene expression observed in
different stages of the life cycle of T. gondii [8] and Plasmodium
falciparum [9]. However, that certain DNA motifs are
recurrent in the promoters of these organisms and bind to
nuclear factors [10 14] suggests that unrecognized tran-
scription factors may exist, but are not encoded by genes with
recognizable structural features. On the other hand, the RNA
polymerase II machinery [7,15] and genes with motifs
indicating potential chromatin remodeling and modiﬁcation
functions [6,16] are conserved within the Apicomplexa.
Epigenetic processes have signiﬁcant clinical relevance in
light of studies that implicate the histone deacetylase Sir2
homolog in regulation of antigenic variation in P. falciparum
[17,18].
To obtain a genome-wide view of gene expression in T.
gondii tachyzoites, we examined the epigenetic organization
and transcription patterns of a contiguous 1% of the T. gondii
genome using custom microarrays. Histone modiﬁcations—
including acetylation of histone H4 (H4ac), acetylation of
lysine 9 (H3K9ac), and trimethylation of lysine 4 of histone
H3 (H3K4me3)—have been identiﬁed at certain individual
active loci in T. gondii [19], suggesting a role in gene
expression. We hybridized the tiled genomic microarrays
with material derived from chromatin immunoprecipitations
using antibodies to modiﬁed histones. By simultaneously
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tested the genome-wide association of speciﬁc histone
modiﬁcations with gene expression.
Results
Microarray Design and Experimental Scheme
We generated a custom oligonucleotide microarray con-
taining 12,995 50-mer features tiling a 650-kb region of
Chromosome 1b, with an average resolution of one oligonu-
cleotide every 50 bp (Figure 1). Chromosome 1b of the RH
strain of the 63-Mb T. gondii genome has been extensively
annotated and has a single nucleotide polymorphism fre-
quency comparable with the rest of the genome, an average of
5.7 exons per coding sequence (CDS), and a gene density of
one gene per 7.4 kb [20]. Currently, 91 genes are predicted
within the 650-kb region of the RH strain of T. gondii.
The amino acid sequences of the tails of eukaryotic
histones H3 and H4 are strongly conserved (Figure S1),
allowing us to use a panel of commercial antibodies for
chromatin immunoprecipitation (ChIP) in T. gondii. After
screening antibodies to modiﬁed histones for T. gondii nuclear
localization (Table 1; Figure S2), we performed ChIP using
DNA isolated from the intracellular tachyzoite stage of T.
gondii. As a control, we used an antibody against a T. gondii
kinase with no DNA-binding potential (M. Gissot and K. Kim,
unpublished data). The immunoprecipitated DNA was am-
pliﬁed, tested to ensure enrichment for control loci was
maintained, and co-hybridized to the 650-kb tiling array with
input DNA.
Modified Histones H4ac, H3K9ac, and H3K4me3 Are
Enriched at Promoter Regions
We studied the distribution of three modiﬁed histones
(H4ac, H3K9ac, and H3K4me3) previously described as
activation marks in other eukaryotes [21,22]. The ChIP
material applied to the microarray (ChIP-chip) generated
strong focal peaks of enrichment for the three different
modiﬁed histones. Signal was readily discriminated from
noise, even looking at the raw ChIP/input DNA ratio (Figure
1), a ﬁnding conﬁrmed by the p-values derived from the use of
the ChIPOTle analytical approach [23], which approached
zero for each locus. We observed 52 clear, discrete, and
coincident H4ac, H3K9ac, and H3K4me3 peaks within the
650-kb region tiled on the microarray (Figure 1B; Table S1).
The H3K9ac and H4ac peaks have a median size of 1,550 bp,
whereas the H3K4me3 peaks are relatively smaller (median
size of 1,300 bp; Table 1).
As previously observed for other eukaryotes [21,22], these
modiﬁcations co-localize and associate to form a complex
pattern at focused loci in the T. gondii genome (Figure 1).
More than 96% of the H3K4me3, H3K9ac, and H4ac (Figure
1B) peaks are placed in the predicted intergenic regions.
Moreover, the identiﬁed peaks for the three modiﬁcations are
located close to the 59 of predicted genes. Indeed, the
distance between the identiﬁed peak and the start codon of
the closest gene is less than 1,000 bp for more than 85% (45/
52) of the H3K9ac and H4ac peaks (Table 1), and less than
1,500 bp for more than 90% (48/52). Similarly, for more than
90% (49/52) of H3K4me3 peaks, the end of the peak and the
ﬁrst predicted initiation codon was within 1,000 bp (Table 1).
Modified Histone H3R17me2 Is Enriched at a Subset of
Promoter Regions, but H3K4me1 and H3K4me2 Are Not
Enriched at Promoters
We also performed ChIP using antibodies against histone
H3 dimethylated at arginine 17 (H3R17me2), another
putative general activation mark in T. gondii [19] and other
eukaryotes [24,25]. Recently, it was suggested that this histone
modiﬁcation is present at all active promoters in T. gondii [19]
based upon PCR examination of selected promoters after
ChIP with anti-H3R17me2. Using the same antibody, we show
that this modiﬁcation is restricted to a subset of promoters
(Figure 1B). This histone mark overlapped with only four of
the 52 modiﬁed histone peaks identiﬁed (4.5% of the genes
present on the microarray). All four genes have expressed
sequence tags (ESTs) for both tachyzoite and bradyzoite
stages.
The H3K4me1 and H3K4me2 marks were also investigated
using ChIP-chip and were not speciﬁcally enriched, as
determined by analysis of hybridizations by the ChIPOTLe
software (unpublished data). We also veriﬁed that the
modiﬁed histone peaks identiﬁed were not due to local core
histone enrichment by performing ChIP-chip with an anti-
body speciﬁc to the C-terminus histone H3.
ChIP Validation of Genome Array Hybridization Results
The ChIP-chip results were validated using quantitative
single-locus PCR (Figure 2 is representative of eight loci
validated). Using real-time quantitative PCR on ChIP samples,
we ampliﬁed regions within the predicted gene (primer set 1)
or in intergenic sequences (primer sets 2 6). We found
enrichment of the three modiﬁed histones in regions
identiﬁed as peaks in the ChIP-chip experiments (primer
sets 2, 3, 5, and 6). In contrast, the three activation marks
tested were not signiﬁcantly enriched in a region located
within the predicted gene (primer set 1) and a region between
the two identiﬁed peaks (primer set 4). We also veriﬁed that
there was no signiﬁcant local enrichment of the core histone
H3 (positive PCR for all primer sets).
Distribution of Modified Histone Peaks Correlates with
Gene Expression
To verify the link between the modiﬁed histone peaks and
transcription of the nearest predicted gene, we hybridized
cDNA made from intracellular tachyzoites to the tiled
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Author Summary
Apicomplexan parasites, including Toxoplasma gondii, are respon-
sible for a variety of deadly infections, but little is understood about
how these important pathogens regulate gene expression. Initial
studies suggest that alterations in chromatin structure regulate
expression of virulence traits. To understand the relationship of
chromatin remodeling and transcriptional regulation in T. gondii, we
characterized the histone modifications and gene expression of a
contiguous 1% of the T. gondii genome using custom DNA
oligonucleotide microarrays. We found that active promoters have
a characteristic pattern of histone modifications that correlates
strongly with active gene expression in tachyzoites. These data,
integrated with prior gene predictions, enable more accurate
annotation of the genome and discovery of new genes. Further,
these studies illustrate the power of an integrated epigenomic
approach to illuminate the role of the ‘‘histone code’’ in regulation
of gene expression in the Apicomplexa.microarray (Figure 3). Using three different analytical
approaches, we identiﬁed regions on the tiled portion of
the genome with signiﬁcant gene expression (Table S1).
Overall, 51 of the 52 regions with a cluster of H3K9ac, H4ac,
and H3K4me3 peaks had a signiﬁcant cDNA hybridization
signal adjacent to them. These data were consistent with EST
studies, with 46 of the 49 genes represented by at least one
EST for the tachyzoite stage expressed in our dataset. In our
study, 31% (21/67) of the genes expressed were not
represented by any EST data, demonstrating the limits of
the EST mapping approach for identifying expressed genes.
Two transcribed loci did not correspond to a predicted
gene (Table S1). One locus had associated H3K9ac, H4ac, and
H3K4me3 peaks characteristic of active chromatin and
corresponded to a transcription unit represented by two
overlapping tachyzoite ESTs (CN197705 and CK737836). A
partial open reading frame (ORF) was discovered after
alignment of those ESTs. After comparing this sequence with
the nr database (http://www.ncbi.nlm.nih.gov/BLAST), we
found the ORF had homology with the cytochrome oxidase
subunit III (COX3) gene of Plasmodium (highest p-value ¼ 5e-
06). This gene is not annotated in the current version of the T.
gondii genome (http://www.toxodb.org). The other locus was
also represented by an EST (BG659482) and appears to be
driven by a promoter that displays promoter activity in both
directions (Table 2). However, this transcribed locus does not
have an ORF and appears to represent a non-coding RNA.
We also found two regions of clustered genes with stage-
speciﬁc expression based on EST data. One region predicts a
set of ﬁve tandemly arrayed kinases with ESTs primarily from
the oocyst stage (Figure 3A). Another region is characterized
by ﬁve genes predicted as BSR4 homologues with ESTs
Figure 1. ChIP-on-Chip Experiments Using ‘‘Activation’’ Histone Markers
(A) Genomic view of Chromosome 1b. Linear representation of Chromosome 1b (2 Mb) with the position of the 650,000-bp region tiled on the
NimbleGen chip. The positions of high significance H3K9ac peaks are indicated with vertical lines. The chip encompassed the region from 1,230,000 to
1,880,000 bp of Chromosome 1b of the T. gondii RH strain. Sequences of the tiled oligonucleotides can be obtained from the Gene Expression Omnibus
database (see Supporting Information).
(B) ChIP-on-chip hybridization. Paired tracings of raw data (top tracing) and the distribution of peaks (lower tracing) for ‘‘activation’’ marks H3K4me3
(red), H3K9ac (green), H4ac (blue), and H3R17me2 (orange) within a 650-kb region of Chromosome 1b. Data are presented as the log2 ratio of the
hybridization signal given by DNA immunoprecipitated using the indicated antibody compared with the signal given by the input DNA sample. The
positions of the 91 predicted genes (CDS, light blue bars; from start to stop codons; up ¼ sense; down ¼ antisense) and tachyzoite ESTs (purple) are
presented. The scale is indicated on the left side of the figure and the position on the sequence at the top. H4ac peaks corresponding to the H3R17me2
peaks are boxed. Genomic positions correspond to the region of Chromosome 1b investigated (position 0 in the region is position 1,230,000 in
Chromosome 1b).
doi:10.1371/journal.ppat.0030077.g001
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cant expression during the tachyzoite stage could be detected,
and neither region had any of the three histone modiﬁcation
peaks characteristic of active chromatin. For the bradyzoite-
speciﬁc locus, two ESTs were recovered from a Type III strain
(VEG) tachyzoite cDNA library. These ESTs could reﬂect
differences in gene expression between strains or represent
the low level of bradyzoite forms frequently present in Type
II and Type III tachyzoite cultures.
Regions Encompassing H4ac and H3K9ac Peaks Are Able
to Drive Luciferase Expression
To test that the clustered peaks were located at active
promoters, we performed luciferase reporter assays (Table 2;
Figure 4A and 4B). We cloned regions spanned by the H3K9ac
and H4ac peaks and tested their ability to drive the
expression of the luciferase in transient transfection assays.
Of the 12 loci tested, 11 were able to drive expression of
luciferase (Table 2; Figures 4 and S3).
Regions 59 of non-expressed genes that lacked clustered
peaks of modiﬁed histones or regions spanned by a predicted
ORF are not able to drive the expression of luciferase (Table
2; Figure S3). However, the two loci with overlapping
H3K4me3, H3K9ac, and H4ac peaks located within rather
than 59 to annotated gene coding regions were both able to
drive the expression of a reporter gene (Table 2; Figure 4B).
Of the 52 activation peaks identiﬁed, only one lacked
evidence of mRNA expression in its vicinity. This peak is
located 59 to a predicted gene (Tg1b.2420), a locus with the
characteristics of a DNA-repair protein, but not associated
with any EST in the T. gondii database at any stage of the life
cycle. The promoter of this gene yielded a background
activity as low as the untransfected parasites (Table 2; Figure
S3).
The H3K4me3 Mark Predicts Directionality of the
Promoter
H3K4me3 peak distribution is consistently shifted toward
the 59 end of genes in comparison with H3K9ac (unpublished
data) and H4ac peaks (Figure 4C and 4D). PCR studies
conﬁrmed that the shift of the H3K4me3 peak predicts the
orientation of transcription. (Four genes were tested with two
represented in Figure 2.) As predicted by these data, most of
the sequences tested have directional activity, as would be
expected for genuine promoters (Table 2; Figure 4C and 4D).
However, seven of the 52 peaks are located in regions where
two genes are transcribed in opposite directions, providing
biological evidence for sequences in T. gondii that have
promoter activity in both directions as shown in other
Apicomplexa [26].
Integration of ChIP-chip and Gene Expression Data
Improves Annotation of the Genome
As illustrated, H3K4me3, H3K9ac, and H4ac peaks identify
promoters. We also found seven predicted genes (as deﬁned
in [20]) that were expressed but lacked modiﬁed histone
peaks at their predicted promoter. In all such cases, these
genes are preceded within 1,000 bp by an expressed gene that
is transcribed in the same direction and bears histone
activation peaks at its 59 end. These genes likely represent
gene prediction errors, since RT-PCR in two cases conﬁrmed
a single transcription unit with the adjacent gene (Figure S4).
Discussion
We have employed an integrative approach to epigenom-
ics, combining simultaneous analysis of ChIP-on-chip and
gene expression on a tiling array encompassing a 0.65-Mb
contiguous portion of the T. gondii Chromosome 1b. The
H3K9ac, H4ac, and H3K4me3 modiﬁcations co-localize at
focused loci in the T. gondii genome and correlate with
signiﬁcant gene expression. We conﬁrmed that the enrich-
ment observed was not due to local enrichment of the H3
core histone by performing ChIP with an antibody directed
against the C-terminus of the histone H3. In contrast, in T.
gondii, the H3K4me1 and the H3K4me2 modiﬁcations are
present at equal amounts in active and inactive chromatin as
previously shown for human promoters [22] and in contrast
to Saccharomyces cerevisiae [23].
To our knowledge, this study is the ﬁrst to explore the
distribution of the H3R17me2 modiﬁcation on a genomic
scale. Surprisingly, this modiﬁcation is enriched only at a
subset of active promoters. Thus, T. gondii uses its histone
modiﬁcation machinery not only as a general landmark of
activated promoters but also to speciﬁcally attribute a
distinctive mark to certain promoters. ESTs have been
sequenced from both tachyzoite and bradyzoite stages for
those four genes, whereas only 26 of the 91 predicted genes










Mean Distance from End
of Peak to First Predicted
Gene (Range) in nt
Percent of the Peaks
within 1,000 nt of the
Start Codon (Peaks/Total)
H3K4me1 Upstate NA NA NA NA
H3K4me2 Upstate NA NA NA NA
H3K4me3 Upstate 52 1,303 (850–2,600) 900 (0–1,800) 94 (49/52)
H3R17me2 Abcam 4 2,180 (1,900–2,400) 195 (0–1,650) 75 (3/4)
H3K9ac Upstate 52 1,550 (700–2,900) 1,600 (350–4,800) 87 (45/52)
H3 Abcam NA NA NA NA
H4ac Upstate 52 1,550 (700–2,900) 1,600 (350–4,800) 87 (45/52)
NA, non-applicable.
doi:10.1371/journal.ppat.0030077.t001
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bradyzoite stages. The H3R17me2 mark may have signiﬁcance
during the tachyzoite to bradyzoite differentiation process,
but the number of loci discovered in this study are too
limited to speculate further upon the speciﬁcity conferred by
this trait. The recent discovery of the importance of arginine
methylation during early development of mouse embryo
indicates a speciﬁc role for the H3R17me2 during differ-
entiation [27].
The H3K9ac and H4ac peaks in T. gondii are larger than
those previously observed in human (approximately 700
nucleotides [nt]) [28] but similar in size to those found in
yeast [23]. It appears that the number of modiﬁed nucleo-
somes is in the same range for these three organisms despite
their difference in genome compaction. Such similarity in the
size of the peaks may have functional implications for RNA
polymerase II.
The placement of the three ‘‘gene activation’’ modiﬁca-
tions coincides, but H3K4me3 peaks are shifted toward the 59
end of expressed genes. This difference has been documented
in human cell lines [29] and predicts the directionality of
promoters in T. gondii. Although most promoters appear to be
orientation-speciﬁc, the tiled region of the T. gondii genome
encodes several regions that exhibit promoter activity in both
directions. Further mapping studies are needed to determine
whether these are true bi-directional promoters or two
separate promoters facing in opposite directions.
We observed an exceptional correlation between gene
expression and the presence of co-localized modiﬁed histone
peaks. The few discrepancies between the EST database and
our gene expression data are likely due to differences in gene
expression between the strain we used (RH, Type I) and the
strains used to generate ‘‘tachyzoite’’ cDNA libraries. Type II
Figure 2. Validation of ChIP-on-Chip Results with ChIP and Real-Time Quantitative PCR
The raw data and the distribution of peaks identified for H3K4me3 (red) and H4ac (blue) are presented for one specific locus. H3K9ac peaks (not shown;
Table 1 and Figure 2) have nearly identical distribution to H4ac peaks. The predicted genes (light blue) are presented at the bottom of the figure
together with the EST data (purple). The scale is indicated on the left side of the figure and the position on the sequence at the top. Real-time
quantitative PCR verification of the ChIP with the indicated antibodies was performed using primers amplifying the six regions indicated by the bars.
The H3K4me3 peaks are shifted toward the 59 end of the gene, indicating the orientation of transcription (compare primer sets 2 and 3). Enrichment
was not significantly changed when the DNA was immunoprecipitated using an anti-H3 antibody, indicating hybridization peaks are not due to
localized nonspecific enrichment of histones.
doi:10.1371/journal.ppat.0030077.g002
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Histone Modifications and Toxoplasma PromotersFigure 3. Gene Expression Correlates with the Enrichment of ‘‘Activation’’ Histone Modifications and EST Mapping
Distribution of identified peaks for H4ac (blue) is presented as shown for two regions of Chromosome 1b (A, B). The raw data (cDNA hybridization
signal) and significant peaks of expression are shown in black. The predicted genes are represented by the light blue boxes (up ¼ sense; down ¼
antisense) and positions of genes with at least one tachyzoite EST are shown in purple. Two regions of clustered stage-specific genes that lack gene
expression and modified histone peaks are underscored by a black bar ([A] oocyst genes, [B] bradyzoite genes).
doi:10.1371/journal.ppat.0030077.g003
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frequently have a low level of basal bradyzoite forms.
One region represented on our array had a cluster of
H3K9ac, H4ac, and H3K4me3 peaks but was unable to drive
luciferase expression. Interestingly, these peaks are located 59
to a gene (Tg1b.2420) predicted to encode a protein similar to
DNA-repair protein XRCC3, a protein essential for ultra-
violet radiation–induced double-strand break repair from
bacteria to mammals [30]. Expression of this gene was not
detected by reverse transcriptase PCR (RT-PCR; Table S1)
and there were no associated ESTs in the T. gondii database at
any stage of the life cycle, which could be explained by rapid
processing or degradation of the mRNA for this gene.
Alternatively, the promoter could be in a poised state waiting
for activation or for the release of a repression, as observed in
a study of rapidly induced genes in human T cells [31]. As
suggested for T cells, the activation marks associated with this
promoter could signify the presence of epigenetic memory in
T. gondii. In a study of human promoters, 20% of those genes
with overlapping H3ac and H3K4me3 marks lacked evidence
of mRNA expression [21].
Prior microarray gene expression studies in T. gondii have
been based upon cDNAs [32] rather than tiled genomic
microarrays. Our survey of tachyzoite gene expression for
this contiguous 1% of the T. gondii genome enabled us to
identify new tachyzoite-expressed genes and discover tran-
scripts in regions where genes have not been predicted. For
example, a cluster of modiﬁed histone ‘‘activation’’ peaks
helped us to identify a gene coding for a cytochrome oxidase
subunit III, which is not annotated in the current version of
the T. gondii genome, and a possible non-coding RNA.
Moreover, our study illustrates the power of empirical
annotation of the genome in terms of promoters and their
transcriptional orientation, enhancing gene prediction ap-
proaches beyond what is currently possible using DNA
sequence-based approaches alone.
In conclusion, we have performed the ﬁrst mapping to our
knowledge of the epigenome of an apicomplexan parasite.
Taken together, the data indicate that T. gondii uses a
multipart histone modiﬁcation system to assign a functional
role to certain DNA sequences and underscores the ability of
this unicellular apicomplexan parasite to employ a complex
set of tools to control its gene expression. These data are
consistent with the extensive repertoire of proteins predicted
to modify histones in the T. gondii genome [16]. Moreover, our
study illustrates the power of empirical annotation of the
genome in terms of promoters and their transcriptional
orientation, enhancing gene prediction approaches beyond
what is currently possible using DNA sequence-based
approaches alone.
T. gondii is a medically important pathogen and is
genetically tractable. It is a powerful model for studying the
gene regulation of apicomplexan parasites and may now
represent a new model system for understanding evolutio-
narily conserved components of the ‘‘histone code.’’ Further,
epigenetic regulators may represent potential therapeutic
targets and provide new tools to ﬁght toxoplasmosis and
other parasitic diseases like malaria.
Materials and Methods
Parasite culture. T. gondii RH strain was maintained in conﬂuent
monolayers of human foreskin ﬁbroblasts (HFF). Parasites were
harvested 24 h after invasion of HFF cells and puriﬁed as previously
described in [33].
Chromatin immunoprecipitation (ChIP). ChIP was performed as
described [34] with slight modiﬁcations. Brieﬂy, chromatin from
intracellular tachyzoites grown in HFF for 24 h was cross-linked for
Table 2. Promoter Activities and Gene Expression of Selected Putative Promoters










1220 2650 1,430 þ Intergenic þþ þ
19751 21044 1,293 þ Intergenic þþ þ




210024 212118 2,094 þ Intergenic þþ þ
283732 285348 1,616 þ Intergenic þ  þ
355294 357201 1,907 þ Intergenic þþ þ
404579 406179 1,600 þ Intergenic þ  þ
537841 539137 1,296 þ Intergenic þþ þ
578555 581159 2,604 þ Intergenic þþ þ
634140 635390 1,250 þ Intergenic     
231824 233674 1,850 þ Gene
a þþ / 
b þ
a
383818 386078 2,260 þ Gene þþ þ
67450 69300 1,850   Intergenic     
274432 275732 1,300   Intergenic     
426896 427896 1,000   Intergenic     
428700 431622 2,922   Intergenic  þ  
571323 573123 1,800   Gene þþ  
Putative promoter regions were cloned and tested for the ability to drive luciferase activity in a transient transfection assay.þindicates positive and indicates negative for each category,
as defined in Materials and Methods.
aIndicates a promoter region that drove luciferase activity in both directions.
bIn this case, the promoter had activity in both directions with an EST for a non-coding RNA present, but no EST for the sense strand of the gene. All other promoters tested were
directional as described in the text. Positions are relative to the beginning of the 650-kb sequence tiled on the genome with annotations as described in [20].
doi:10.1371/journal.ppat.0030077.t002
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Histone Modifications and Toxoplasma PromotersFigure 4. Promoter Activity of Regions with Histone Modifications
(A, B) Predicted promoters drive luciferase expression. Two regions with H4ac peaks (blue) and the position of annotated genes (light blue) are shown
(left). Positions of tachyzoite-specific ESTs are shown in purple. (A) Shows activity for a gene without a predicted EST but with cDNA hybridization. (B)
Shows promoter activity for a peak that lies within a predicted gene coding region but can drive expression of a gene transcribed on the opposite
strand, as determined by EST data and cDNA hybridization. The regions that tested the luciferase reporter assay are boxed. Each sequence was cloned
in the sense and antisense direction (arrows) and showed directional activity. The graph represents Firefly luciferase units normalized to the Renilla
luciferase units of the co-transfected constitutive tubulin promoter. Controls included untransfected parasites (no DNA) or parasites transfected with
the Firefly luciferase reporter under the control of LDH2, a bradyzoite-specific promoter not expressed at this stage of the life cycle [39].
(C, D) H3K4me3 peaks are shifted toward the 59 end of genes. Raw data and the distribution of H3K4me3 (red) and H4ac (blue) peaks are presented.
H3K9ac peaks (not shown) have nearly identical distribution to H4ac peaks. The predicted genes (CDS) are represented by the light blue boxes (up ¼
sense; down¼antisense). The H3K4me3 peaks are shifted to the 59 end of genes relative to the H4ac peaks (Positions of the ends of H3K4me3 peaks are
illustrated with a dotted line to facilitate comparison). The scale is indicated on the left side of the figure and the position on the sequence at the top.
(D) Also shows a broad H3K4me3 peak that encompasses an H4ac peak, which corresponds to an intergenic region that displays promoter activity in
both directions.
doi:10.1371/journal.ppat.0030077.g004
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after a sonication step yielding fragments of 500 1,000 bp.
Immunoprecipitations were performed with the appropriate rabbit
serum (Table 1) at 4 8C overnight and washed extensively as published
previously [34]. DNA was further subjected to a treatment with
proteinase K for 2 h and then puriﬁed using the Qiagen PCR
puriﬁcation kit (http://www.qiagen.com). As a negative control, we
used rabbit antiserum to PKA2, a kinase that is not present in the
nucleus (M. Gissot and K. Kim, unpublished data).
Design of the Nimblegen oligonucleotide microarray and ChIP-on-
chip. We generated a tiled array of 50-bp oligonucleotides with
12,295 oligos encompassing 650,000 bp (1,230,000 1,880,000) of
Chromosome 1b [20] with a spacing of 50 bp between each
oligonucleotide. The array was fabricated in the NimbleGen Systems
(http://www.nimblegen.com) 12-plex format, which allows simulta-
neous hybridization of 12 identical arrays on a single slide.
Ampliﬁcation of immunoprecipitated DNA and 100-ng input DNA
was performed using the ligation-mediated PCR technique [35]. After
ampliﬁcation, the immunoprecipitated DNA was tested for enrich-
ment of control loci by qPCR and co-hybridized to the 650-kb tiling
array with input DNA. DNA was labeled using random primers
coupled to a ﬂuorochrome and hybridized according to NimbleGen
Systems procedures. At least two biological replicates were per-
formed.
Real-time quantitative PCR. Real-time quantitative PCR was
performed on the 7300 ABI apparatus using the Power Sybr (ABI,
http://www.appliedbiosystems.com) mastermix in a 20-lL volume
according to the manufacturer’s instructions. PCR primers were
designed using the Primerexpress software (ABI) to amplify regions of
100 150 nt. A 10-fold dilution of input was compared with 0.5 ng of
immunoprecipitated DNA. Each experiment was performed at least
three times in duplicate.
Tachyzoite gene expression. The RNA from three replicate ﬂasks
containing RH strain–infected HFFs and one control ﬂask containing
only HFFs was puriﬁed using TRIzol. RNA integrity was veriﬁed on
the Agilent Bioanalyzer (http://www.agilent.com). Ten micrograms of
total RNA was retrotranscribed using the BD Sprint Powerscript kit
(http://www.bdbiosciences.com) and random hexamers and made
double-stranded cDNA (dscDNA) using Escherichia coli polymerase I.
dscDNA labeling with ﬂuorochrome-coupled random hexamer and
hybridization to the array was performed following NimbleGen
protocols. NimbleGen scanning and spot ﬁnding software were used.
Statistical analysis of array data. Signiﬁcant peaks for ChIP-on-
chip were identiﬁed with the ChIPOTle software [23] using a
permutation simulation to estimate the background distribution
(with a window size of 500 bp, 300 permutations, and a p-value of
0.001). Peaks with a p-value of less than 10
 10 (which produces about
50 times more signiﬁcant regions than false regions) and with a peak
height cut-off of 2 were considered signiﬁcant. The false discovery
rate was 0.1%.
After background correction using random probes, gene expres-
sion was calculated as the average of the log2 ratio of the intensity
given by the HFF plus parasite dscDNA to the intensity given by the
HFF-alone dscDNA. With ChIPOTle, expression was considered
signiﬁcant with a p-value , 0.05 and a high average ratio above 1
or 0.6. Peaks of signiﬁcant expression were also identiﬁed using the
detection peaks tool in SignalMap software with a sliding window of
150 bp and a log2 ratio threshold of 1 or 0.8. A peak is identiﬁed when
there are at least four data points within a window above the
threshold value. The height of the peak is the maximum of the data
points within the window. In addition, the raw log2 ratios were
normalized using loess regression to remove the dependence of the
variance on the mean and partitioned into segments along the
chromosome with the function segmentation within the Bioconductor
package ‘‘tilingArray’’ (http://www.bioconductor.org) [36], using 300
and 3,000 for the maxseg and maxk arguments, respectively. Since a
one-to-one correspondence between the segments and the gene
annotations does not exist (e.g., when several adjacent genes are not
transcribed), tests of signiﬁcance were carried out using the means of
the probes that mapped fully to each annotated gene. The intensity
threshold between the untranscribed and transcribed segments was
determined by ﬁtting a mixture model to the segment means using
the ‘‘mclust’’ package from Bioconductor [36]. The signiﬁcance of
expression for each annotation was calculated using the binomial test
on the signs of the differences between the probe intensities and the
threshold [37]. The p-values were adjusted for multiplicity using the
Benjamini–Yekutieli procedure from the ‘‘multtest’’ package of
Bioconductor [36] with a false discovery rate of 0.1%.
Luciferase reporter assay. Regions of T. gondii DNA (Tables 2 and
S1) were subcloned into pCR8-GW vector (Invitrogen, http://www.
invitrogen.com), sequenced, and cloned into a Gateway vector
expressing Fireﬂy luciferase. Plasmid (50 lg) was co-transfected with
20 lg plasmid expressing Renilla luciferase under the control of the
Tubulin promoter (both plasmids gift of M. W. White, Montana State
University) following standard transfection protocols [38]. Luciferase
assay was performed after 24 h using the Promega Dual-Luciferase
Kit (http://www.promega.com) according to manufacturer instruc-
tions. Each assay was repeated three times in duplicate.
Gene prediction criteria and ESTs databases. Gene predictions
were as described in Khan et al. [20]. The sequences corresponding to
the CDS were extracted for a 650-kb region of the RH strain
Chromosome 1b [20] and were set up as a BLAST database using the
BLAST program downloaded from NCBI (http://www.ncbi.nlm.nih.
gov/BLAST). We then used a perl script to blast the 88,535 EST
sequences downloaded from the ToxoDB Web site (http://www.
toxodb.org/download/release-3.3/EST/nuc) against the BLAST data-
base. The e-value cut off of e-25 was considered signiﬁcant.
Supporting Information
Figure S1. Alignment of H3 and H4 Histones
Sequences for T. gondii (Tg), P. falciparum (Pf), Homo sapiens (Hs), S.
cerevisiae (Sc), and Drosophila melanogaster (Dm) H3 and H4 histones
retrieved from the Histone Sequence Database (http://research.nhgri.
nih.gov/histones) with a consensus sequence. Red letters represent the
amino acids that are present in more than 90% of the sequences, and
blue residues are present in at least 50% of the sequences.
Found at doi:10.1371/journal.ppat.0030077.sg001 (3.2 MB TIF).
Figure S2. T. gondii Nuclei Are Labeled with Antibody Recognizing
Modiﬁed Histones
Commercial antibodies (FITC; green) speciﬁc for histone modiﬁca-
tions H3K4me3 (SF2A), H3K9ac (SF2B), and H4ac (SF2C) label the
nucleus of the parasite (DAPI; blue). The phase-contrast images are
presented in the right panel.
Found at doi:10.1371/journal.ppat.0030077.sg002 (2.7 MB TIF).
Figure S3. Promoter Assays of Selected Regions of Chromosome 1b
The graph represents Fireﬂy luciferase units normalized to Renilla
luciferase counts (driven by constitutive tubulin promoter). Normal-
ized counts for parasites transfected with Fireﬂy luciferase under the
control of (1) the bradyzoite-speciﬁc promoter LDH2 (not expressed
in the tachyzoite stage); (2) no DNA; (3) a region not predicted to be a
promoter; (4) the probable promoter region of a predicted gene with
neither ‘‘activation’’ histone peaks nor cDNA hybridization; (5) and
(6) the ‘‘promoter’’ of the DNA-repair protein XCCR3 homolog
(sense ¼ 5 and antisense ¼ 6), the only gene that had ‘‘activation’’
modiﬁed histone peaks but no cDNA hybridization; (7) the promoter
of an expressed gene (positive cDNA hybridization) with peaks of
modiﬁed histone enrichment.
Found at doi:10.1371/journal.ppat.0030077.sg003 (409 KB TIF).
Figure S4. Integration of ChIP-on-Chip and Expression Data Enables
Improved Genome Annotation
Distribution of identiﬁed H3K9ac peaks is illustrated in green. The
moving average of the normalized expression data (cDNA hybrid-
ization signal) and signiﬁcant peaks of expression are shown in black.
The predicted genes are represented by the light blue boxes (up ¼
sense; down ¼ antisense; TgIb.1810c, TgIb.1800c, TgIb.1790c now
represented by 25m0080, 25m0081 in ToxoDB version 4.1, http://www.
toxodb.org). These CDS are marked from the predicted start and stop
codon and do not reﬂect the likely presence of introns (as suggested
by the discontinuous areas of cDNA hybridization seen on the
microarray). The regions ampliﬁed by RT-PCR are boxed in red. The
result of the RT-PCR is shown below. The presence (þ) or the absence
( ) of the reverse transcriptase enzyme in the RT reaction is indicated
at the top of the gel.
Found at doi:10.1371/journal.ppat.0030077.sg004 (2.2 MB TIF).
Table S1. Summary of Signiﬁcant ChIP-on-Chip Peaks with Asso-
ciated Expression Data
The 52 signiﬁcant ChIP-on-Chip peaks identiﬁed by Chipotle
software are listed with their position and size of peak (H3K4me3,
H3K9ac, and H4ac peaks overlapped). From the results of the
Chipotle and SignalMap analyses, signiﬁcant hybridization compared
with control for individual experiments and pooled data from all
three experiments are indicated when using a threshold of 1 (log2; i.e.,
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each histone activation peak. Red þ signs indicate hybridization
present with only the lower threshold. RT-PCR was used to verify
expression for the indicated genes. Fifty of 52 peaks had a region of
cDNA hybridization within 1,000 bp. Peaks with corresponding
tachyzoite ESTs are indicated. The signiﬁcance of the means of the
probes that map fully to the gene annotations and gene annotations
with intensities above the threshold for transcription (identiﬁed
using the segmentation analysis) are shown for peaks within 1,000 bp
of an annotated gene (þþþ, p , 0.001;þþ, p , 0.01;þ, p , 0.05: (þ), p ,
0.1; ns, not signiﬁcant). If more than one gene annotation was within
1,000 bp of the peak, then the closest annotation was tabulated. In six
cases, the annotations are not within 1,000 bp of the peaks (x;
distances noted) compared with two peaks that are not within 1,000
bp of transcription peaks (peaks 40 and 51) demonstrating the ability
to improve predicted gene starts. Two veriﬁed (BD) and six possible
(BD?) sequences able to drive reporter activity bidirectionally are
indicated. Gene annotation numbers as described in [20].
Found at doi:10.1371/journal.ppat.0030077.st001 (200 KB PDF).
Accession Numbers
The European Bioinformatics Institute (http://www.ebi.ac.uk) acces-
sion numbers of genes and proteins used in this study are TgIb.1560c;
TgIb.1570; TgIb.1580c; TgIb.1590; TgIb.1600; TgIb.1610c; TgIb.1620;
TgIb.1630c; TgIb.1640; TgIb.1650c; TgIb.1660; TgIb.1670; TgIb.1680c;
TgIb.1690c; TgIb.1700c; TgIb.1710; TgIb.1720c; TgIb.1730c;
TgIb.1740; TgIb.1750c; TgIb.1760c; TgIb.1770c; TgIb.1780;
TgIb.1790c; TgIb.1800c; TgIb.1810c; TgIb.1820; TgIb.1830; TgIb.1840;
TgIb.1850c; TgIb.1860; TgIb.1870c; TgIb.1880; TgIb.1890; TgIb.1900c;
TgIb.1910; TgIb.1920; TgIb.1930c; TgIb.1940; TgIb.1950c; TgIb.1960c;
TgIb.1970; TgIb.1980c; TgIb.1990; TgIb.2000; TgIb.2010c; TgIb.2020;
TgIb.2030; TgIb.2040; TgIb.2050; TgIb.2060; TgIb.2070c; TgIb.2071;
TgIb.2080; TgIb.2090; TgIb.2100c; TgIb.2110; TgIb.2120c; TgIb.2130c;
TgIb.2140c; TgIb.2150c; TgIb.2160c; TgIb.2170c; TgIb.2180c;
TgIb.2190; TgIb.2200; TgIb.2210c; TgIb.2220c; TgIb.2230; TgIb.2240;
TgIb.2250; TgIb.2260; TgIb.2270; TgIb.2280c; TgIb.2290; TgIb.2291;
TgIb.2300; TgIb.2310; TgIb.2320c; TgIb.2330; TgIb.2340; TgIb.2350c;
TgIb.2360c; TgIb.2370c; TgIb.2380c; TgIb.2390c; TgIb.2400;
TgIb.2410; TgIb.2420; TgIb.2430; and TgIb.2440c.
GenBank dbEST (http://www.ncbi.nlm.nih.gov/entrez/query.
fcgi?db¼Nucleotide) accession numbers of ESTs used in this study
are BG659482, CN197705, and CK737836.
Microarray data have been submitted to the Gene Expression
Omnibus database (http://www.ncbi.nlm.nih.gov/projects/geo) under
accession numbers GSM139203–GSM139216 and GSM139134–
GSM139136; the number for the complete series is GSE7262.
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